Tingxun Y. Lu
Suzhou, 215006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Reactivation of cytomegalovirus and its influencing factors in patients with B-lymphocyte malignancy after CAR-T cell therapy
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: January 02, 2025
Identification of molecular clusters and a risk prognosis model for diffuse large B-cell lymphoma based on lactate metabolism-related genes.
Journal: Annals of hematology
Published: December 01, 2024
XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo.
XRCC2 knockdown effectively sensitizes esophageal cancer to albumin-paclitaxel in vitro and in vivo.
Journal: Biochemical genetics
Published: February 23, 2024
Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients.
Journal: Annals of hematology
Published: October 12, 2023
Recent advances in genomics and therapeutics in mantle cell lymphoma.
Journal: Cancer treatment reviews
Published: September 15, 2023
Encouraging prospects with sugemalimab in relapsed or refractory extranodal natural killer/T-cell lymphoma.
Journal: Chinese clinical oncology
Published: July 11, 2023
Prognostic Value of Combined LMR and CEA Dynamic Monitoring in Postoperative Colorectal Cancer Patients.
Journal: Journal of inflammation research
Published: June 13, 2023
Tumor-Infiltrating Normal B Cells Revealed by Immunoglobulin Repertoire Clonotype Analysis Are Highly Prognostic and Crucial for Antitumor Immune Responses in DLBCL.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 22, 2023
The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma.
Journal: Experimental hematology & oncology
Published: May 12, 2023
CD8(+) γδT cell lymphoma of spleen: a case report
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: March 22, 2023
Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.
Journal: International journal of molecular sciences
Published: February 11, 2023
Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer.
Journal: Drug delivery
Published: August 18, 2022
Last Updated: 09/26/2026